Applied Biosciences logo

APPB - Applied Biosciences Share Price

$0.161 0.0  0.0%

Last Trade - 23/02/21

Sector
Healthcare
Size
Micro Cap
Market Cap £2.34m
Enterprise Value £3.39m
Revenue £617k
Position in Universe 6479th / 6715
Bullish
Bearish
Unlock APPB Revenue
Momentum
Relative Strength (%)
1m +12.7%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -81.2%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.046 0.20 0.71
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 31 December 2019, AppliedBiosciences Corp revenues increased 32% to $625K. Net lossincreased 7% to $2.6M. Revenues reflect an increase indemand for the Company's products and services due tofavorable market conditions. Higher net loss reflects FVAdjustments of Financial Investments decrease from $405K(income) to $327K (expense), Depreciation and Amortizationincrease from $1K to $120K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

APPB Revenue Unlock APPB Revenue

Net Income

APPB Net Income Unlock APPB Revenue

Normalised EPS

APPB Normalised EPS Unlock APPB Revenue

PE Ratio Range

APPB PE Ratio Range Unlock APPB Revenue

Dividend Yield Range

APPB Dividend Yield Range Unlock APPB Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
APPB EPS Forecasts Unlock APPB Revenue
Profile Summary

Applied Biosciences Corp. is a vertically integrated company. The Company is focused on the development and commercialization of science-driven, synthetic cannabinoid therapeutics/biopharmaceuticals that target the endocannabinoid system to treat a range of diseases across multiple therapeutic areas. It also delivers consumer and over the counter (OTC) tetrahydrocannabinol (THC)-free cannabidiol (CBD) products, as well as testing and analytics capabilities to its customers.

Directors
Last Annual March 31st, 2019
Last Interim December 31st, 2019
Incorporated February 21, 2014
Public Since November 4, 2015
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 20,252,587
Free Float (0.0%)
Eligible for
ISAs
SIPPs
APPB Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for APPB
Upcoming Events for APPB
Frequently Asked Questions for Applied Biosciences
What is the Applied Biosciences share price?

As of 23/02/21, shares in Applied Biosciences are trading at $0.161, giving the company a market capitalisation of £2.34m. This share price information is delayed by 15 minutes.

How has the Applied Biosciences share price performed this year?

Shares in Applied Biosciences are currently trading at $0.161 and the price has moved by -35.48% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Applied Biosciences price has moved by -50.76% over the past year.

What are the analyst and broker recommendations for Applied Biosciences?

There are no analysts currently covering Applied Biosciences.

When will Applied Biosciences next release its financial results?

Applied Biosciences is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-12-31
What is the Applied Biosciences dividend yield?

Applied Biosciences does not currently pay a dividend.

Does Applied Biosciences pay a dividend?

Applied Biosciences does not currently pay a dividend.

When does Applied Biosciences next pay dividends?

Applied Biosciences does not currently pay a dividend.

How do I buy Applied Biosciences shares?

To buy shares in Applied Biosciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Applied Biosciences?

Shares in Applied Biosciences are currently trading at $0.161, giving the company a market capitalisation of £2.34m.

Where are Applied Biosciences shares listed? Where are Applied Biosciences shares listed?

Here are the trading details for Applied Biosciences:

Country of listing: United States
Exchange: PNK
Ticker Symbol: APPB
What kind of share is Applied Biosciences?

Based on an overall assessment of its quality, value and momentum, Applied Biosciences is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Applied Biosciences share price forecast 2021?

We were not able to load any forecast data for Applied Biosciences.

How can I tell whether the Applied Biosciences share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Applied Biosciences. Over the past six months, the relative strength of its shares against the market has been -63.29%. At the current price of $0.161, shares in Applied Biosciences are trading at -46.26% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Applied Biosciences PE Ratio?

We were not able to find PE ratio data for Applied Biosciences.

Who are the key directors of Applied Biosciences?

Applied Biosciences's management team is headed by:

Chris Bridges - PRE
John Southard - TRS
Scott Stevens - CHM
Michael Beaubaire - DRC
Who are the major shareholders of Applied Biosciences?

Here are the top five shareholders of Applied Biosciences based on the size of their shareholding:

Stevens (Scott B) Individual Investor
Percentage owned: 11.07% (2.24m shares)
Brady (John Robert) Individual Investor
Percentage owned: 10.18% (2.06m shares)
SBS Family Trust Corporation
Percentage owned: 8.89% (1.80m shares)
Southard (John James) Individual Investor
Percentage owned: 1.98% (400k shares)
Bridges (Chris) Individual Investor
Percentage owned: 1.83% (371k shares)
Similar to APPB
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.